Early trials for 'common cold' vaccine offer encouraging signs
A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a phase 1 clinical trial. Initial findings ...
Aug 27, 2026
0
4









